Ozempic, public health, and black markets
Gavin and Jessamy are joined by Oksana Pyzik (UCL, Fight The Fakes Alliance) to discuss how Ozempic/Wegovy/semaglutide works, what becoming mainstream means for our understanding of obesity and public...
11 Heinä 202440min
Women in global health
Anita Zaidi, President of The Gender Equality Division at the Gates Foundation, joins Gavin to discuss women in global health from visibility in data all the way through to women in leadership positio...
13 Kesä 202423min
AI and LLMs in healthcare
Gavin and Jessamy are joined by Rupa Sarkar, editor-in-chief of The Lancet Digital Health, to discuss the uses of Large Language Models (LLMs) in healthcare, the safety and patient concerns, progress ...
30 Touko 202432min
The hidden costs of breast cancer
What are the hidden costs of breast cancer? What advances in breast cancer treatment have been made, and how can we tackle the problematic inequities that remain? What needs to be done for patients wi...
16 Touko 202439min
Race & Health: Intersectionality
In our final episode of this collaboration between the Race & Health podcast and The Lancet Voice, intersectionality brings three researchers together to discuss how intersectionality can serve the he...
2 Touko 202431min
Race & Health: History of medical racism
Race and racism are based in history, and how humans thought about the physical differences. Early conceptions of these differences were focused on physical adaptations across geographies around the w...
11 Huhti 202440min
Early menopause
Jessamy and Gavin are joined by Prof. Gita Mishra, life course epidemiologist at the University of Queensland, to discuss her work on understanding early menopause. How many women does early menopause...
4 Huhti 202426min
Race & Health: Epistemic injustice
Whose knowledge is represented in our health research, policies, and practice? Who is heard, listened to and believed in our health system, and why? There are differences in not only whose perspective...
14 Maalis 202435min
